Cytoplasmic expression of BAP1 as an independent prognostic biomarker for patients with gliomas.

Abstract

This study suggested that cytoplasmic expression of BAP1 might be served as a valuable predictive biomarker of the prognosis in gliomas. High cytoplasmic expression of BAP1 might be benefit to identify patients who need to carry out further therapy.